Incidence of cardiovascular adverse events (AEs) in resected non-small cell lung cancer (NSCLC) patients receiving adjuvant platinum-based chemotherapy: a single institution experience from Wythenshawe Hospital, Manchester, UK. (January 2020) - Birley, J.; Summers, Y.; Taylor, P.; Beanland, L.; Lam, C.; Califano, R.; Cove-Smith, L.